Blue Biotechnology
Will be published approx. on 30. September 2016
Book
Paperback/Softback
54 pages
978-1-84929-152-1 (ISBN)
Description
This fifth volume in the Commonwealth Blue Economy Series, Blue Biotechnology, provides a high-level assessment of the opportunities available for economic diversification through the development of a blue biotechnology sector in SIDS for food, health products and pharmaceuticals. It examines relevant examples from around the world, and outlines specific enabling conditions that could assist in moving such a blue biotechnology sector towards becoming an economic reality where opportunities exist.
More details
Series
Language
English
Place of publication
London
United Kingdom
Target group
Professional and scholarly
Dimensions
Height: 253 mm
Width: 190 mm
ISBN-13
978-1-84929-152-1 (9781849291521)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Content
Acronyms and Abbreviations
Summary
1 Introduction
1.1 Developing a blue economy
1.2 Blue biotechnology
References
2. Blue Biotechnology: A Rapidly Developing and Evolving Sector of the Blue Economy
2.1 Blue biotechnology assets
2.2 Bioprospecting and blue biotechnology beyond pharma
End notes
Reference
3 Options and Technologies for Blue Biotechnology
3.1 Blue biotechnology: opportunities across the value pyramid
3.2 Fucodian: An example of commercial potential
End notes
References
4 Enabling Conditions
4.1 Ownership of biological resources
4.2 Bioprospecting options
4.3 Facilitation of research and entrepreneurship
4.4 Developing a centralised biological resource centre
4.5 The SIDS' brand References
5 Conclusion and Recommendations
5.1 Conclusions
5.2 Recommendations for fostering the development of blue biotechnology
5.3 Blue economy implementation
Reference
Glossary
Summary
1 Introduction
1.1 Developing a blue economy
1.2 Blue biotechnology
References
2. Blue Biotechnology: A Rapidly Developing and Evolving Sector of the Blue Economy
2.1 Blue biotechnology assets
2.2 Bioprospecting and blue biotechnology beyond pharma
End notes
Reference
3 Options and Technologies for Blue Biotechnology
3.1 Blue biotechnology: opportunities across the value pyramid
3.2 Fucodian: An example of commercial potential
End notes
References
4 Enabling Conditions
4.1 Ownership of biological resources
4.2 Bioprospecting options
4.3 Facilitation of research and entrepreneurship
4.4 Developing a centralised biological resource centre
4.5 The SIDS' brand References
5 Conclusion and Recommendations
5.1 Conclusions
5.2 Recommendations for fostering the development of blue biotechnology
5.3 Blue economy implementation
Reference
Glossary